TG-101001

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameTG-101001
Drug Alias NameRaf kinase inhibitor (TargeGen/Anticancer)KG-5TG-101001
ClassificationSmall molecules
Mechanisms of ActionAngiogenesis inhibitorsAnticancer protein kinase inhibitorsRAF serine/threonine protein kinase inhibitors
TargetsRAF serine/threonine protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTargegen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnticancer IncTargegen Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A